한국어
English
日本語
中文(简体)
Itovey Bejeong 3 mg (Inavolisib)
3mg
Tablet · Prescription medication
Roche Korea Ltd.
Inavolisib is an anticancer agent that inhibits the growth of certain cancer cells.
MFDS ingredient code M285705
Inavolisib is a molecule belonging to the class of anticancer agents, used to slow down or stop the progression of cancer by blocking abnormal signaling in cancer cells. It is primarily used in the treatment of cancer patients with specific genetic mutations.
Inavolisib inhibits the activity of certain enzymes within cancer cells, blocking signals that promote excessive cell proliferation. This results in the suppression of cancer cell growth and a reduction in tumor size.
Approved uses differ by product. Check each product's information for its actual use.
Inavolisib is a targeted therapy that selectively acts on specific genetic mutations, characterized by minimizing damage to normal cells compared to conventional chemotherapy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
